Wei Zhang

机构：Nanchang University, Lanzhou University Second Hospital, First Affiliated Hospital of Nanchang University, Lanzhou University · ORCID：0000-0002-2756-459X

发表论文 33 篇 · 总被引 934 次 · h-index 13

代表论文

• Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial (2021 · Journal of Thoracic Oncology · 被引 323)
• Effect of low‐to‐moderate‐dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia (2017 · Influenza and Other Respiratory Viruses · 被引 146)
• Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer (2024 · JAMA Oncology · 被引 63)
• On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial (2022 · Molecular Cancer · 被引 54)
• Propofol exposure during late stages of pregnancy impairs learning and memory in rat offspring via the BDNF ‐TrkB signalling pathway (2016 · Journal of Cellular and Molecular Medicine · 被引 31)
• Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency (2024 · Maturitas · 被引 26)